Hyperbaric oxygen therapy (HBOT) has been FDA approved to treat numerous medical conditions. The FDA has continued to add new conditions as new scientific studies are being published proving that HBOT can be beneficial in numerous inflammatory conditions. At Heal Body Wellness Clinic treatment is provided for on and off-label conditions under the guidance of the International Hyperbaric Association and the International Board of Underseas Medicine. 

Hyperbaric oxygen is changing the field of medicine and according to a new study by The New England Journal of Medicine, HBOT has led to a 75% decrease in amputations in diabetic patients. Wound healing has been aided by HBOT due to the promotion of growth factors, increased blood vessel growth and the anti-inflammatory actions of oxygen under pressure. These same mechanisms are found to treat a number of other conditions.

 

At Heal Body Wellness our hyperbaric chambers are approved by the FDA to treat many medical conditions. Additionally, HBOT is approved by Medicare to treat the following conditions:

  • Air or Gas Embolism
  • Carbon Monoxide Poisoning
  • Chronic Osteomyelitis
  • Compartment Syndrome/Crush Injury/Other Traumatic Ischemias
  • Compromised Skin Grafts and Flaps
  • Decompression Sickness (Bends)
  • Diabetic and Selected Wounds
  • Exceptional Blood Loss (Anemia)
  • Gas Gangrene
  • Intracranial Abscess
  • Necrotizing Soft Tissue Infection
  • Osteoradionecrosis and Radiation Tissue Damage
  • Thermal Burns
  • Sudden Sensorineural Hearing Loss

  

HBOT has been shown to be beneficial with the following off-label conditions:

  • Fibromyalgia
  • Lyme Disease
  • Migraine
  • Multiple Sclerosis
  • Near Drowning
  • Post traumatic stress disorder (PTSD)
  • Recovery from Plastic Surgery
  • Sports Injuries
  • Stroke
  • Traumatic Brain Injury
  • Addiction
  • Autism
  • Anoxic Brain Injury
  • Avascular Necrosis
  • Cerebral Palsy
  • Crohn’s Disease
  • Circulation conditions
  • Concussion
  • Complex Regional Pain Syndrome
  • Post-COVID-19 condition (Long COVID)

Latest Research